VetClick
Menu Menu
Login

VetClick

/ News
Tuesday, 13th May 2025 | 2,430 veterinary jobs online | 113 people actively seeking work | 5,541 practices registered

Veterinary Industry News

Send us your news

HT Vista Joins SPVS Partner Programme To Support Veterinary Practices With Exclusive Discounts

2 weeks ago
207 views

Posted
28th April, 2025 09h19

Author
Companion Consultancy


HT Vista, the creator of the world’s first non-invasive medical device for screening cancer in dermal and subcutaneous masses in dogs, has officially joined the Society of Practising Veterinary Surgeons (SPVS) Partner Programme.

As part of the collaboration, SPVS members will now have access to exclusive discounts on all HT Vista subscription plans, helping practices enhance their diagnostic capabilities while driving efficiency, revenue and patient care.

“We’re proud to partner with SPVS and support its mission of helping veterinary practices thrive,” said Dr Liron Levy-Hirsch, Managing Director at HT Vista. “This collaboration makes it even easier for SPVS members to adopt innovative tools that streamline processes, elevate patient care and create new revenue opportunities.”

SPVS members can now access 10% off all HT Vista subscription plans through the SPVS Partner Programme and practices typically see return on investment within 4–6 months, as the device encourages more investigations while building trust and engagement.

 “As well as improving patient care, the HT Vista is a sound business choice for practices.” Liron adds, “The feedback and data we receive from practices who already have the HT Vista, is that using the device increases the number of FNAs, biopsies and excisional surgeries that are performed. The device helps to not only justify further testing in situations where owners may have been on the fence, but it also identifies potential malignancies which could have been missed with palpation alone.”

HT Vista, which uses cutting-edge heat diffusion imaging and AI-powered analysis to assess the risk of malignancy in dermal and subcutaneous masses, is already in use across a growing number of practices globally.  It offers a reliable way to screen masses in-house and on the spot, transforming the traditional “wait and see” approach into faster clinical decisions and earlier interventions.

For clients, this offers reassurance and faster answers. For practices, it boosts compliance, drives follow-up diagnostics and surgery, and improves the client experience.

SPVS choose to partner with organisations to bring its members exclusive offers which have been selected for the value they bring to practising professionals, with most tested or used by members of the SPVS Board. While SPVS does not officially endorse partner products or services, members are encouraged to explore the available options and assess how they meet the needs of their own practice. 

HT Vista will also be exhibiting at SPVS Congress 2026 and looks forward to engaging with SPVS members at the event to share how this innovative technology can support their clinical and commercial goals.

To find out more about HT Vista or book a quick discovery call with an expert, visit: www.ht-vet.com


More from Companion Consultancy


You might be interested in...